Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Microscience advances oral typhoid vaccine into U.S. clinical trials

Oct. 11, 2002

Aventis Pasteur patents multivalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine

Oct. 9, 2002

ICAAC abstract details mechanism of action, effects in murine model of GVHD for PNP inhibitor

Oct. 7, 2002

Helivax to enter phase II Helicobacter trials

Oct. 7, 2002

Shionogi describes the isolation of IL-12 production inhibitor from plant

Oct. 7, 2002

Genteric receives SBIR grant to evaluate DNA vaccines

Oct. 4, 2002

Avant announces phase II Peru-15 results

Oct. 3, 2002

Two Shionogi patents describe novel immunosuppressant agents

Oct. 2, 2002

Novel immunosuppressants in early development at Sumitomo

Oct. 1, 2002

Positive phase I results for AGI-1096 in prevention of transplant rejection

Oct. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...